Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
PPD Pharmaceutical Development (Beijing) Co., Ltd. (formerly known as Beijing Pharmaceutical Consulting Co., Ltd. or 北京法马苏提克咨询有限公司, and currently registered as 百时益医药研发(北京)有限公司) is the Chinese subsidiary of PPD, a leading global contract research organization (CRO). Now operating as part of Thermo Fisher Scientific following its acquisition in December 2021, the company provides comprehensive clinical trial management, clinical data processing, medical registration, and regulatory consulting services in China. It supports global and domestic pharmaceutical and biotechnology companies in navigating clinical development and regulatory pathways to bring innovative therapies to the Chinese and global markets.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on 北京法马苏提克咨询.